Early Childhood CASPR2 Autoimmunity with Prominent Autonomic Dysfunction: Diagnostic Challenges and Effective Immunotherapy

CASPR2-associated neurological diseases cover a broad clinical spectrum, with limbic encephalitis and Morvan syndrome representing the most characteristic autoimmune phenotypes. We report the case of a 2-year-old boy who presented with abdominal and generalized pain, refusal to eat or drink, weight loss, loss of mobility, and behavioral changes, including sleep disturbances. Further clinical evaluation revealed pharmacoresistant arterial hypertension and hyperhidrosis. Extensive diagnostic testing excluded infectious and toxic causes. CASPR2 antibodies were detected in both serum and cerebrospinal fluid. Initial therapy with corticosteroids and intravenous immunoglobulins resulted in only minimal clinical improvement. Significant clinical recovery was only achieved after escalation of immunotherapy with plasmapheresis and subsequent B-cell–depleting therapy with rituximab. At the most recent follow-up visit, seven months after the first rituximab infusion, the patient showed complete recovery without residual symptoms. This case underscores the diagnostic challenges of CASPR2-associated autoimmunity in early childhood and highlights the importance of early recognition of this rare but treatable disease.

Authors

Institutions

Publication Details

Journal
Neuropediatrics
Published
2026-11-19
DOI
https://doi.org/10.1055/a-3006-7350
Primary Topic
Autoimmune Neurological Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Early Childhood CASPR2 Autoimmunity with Prominent Autonomic Dysfunction: Diagnostic Challenges and Effective Immunotherapy

Lena Meyer-Ruhnke, Lara Maleen Marten, Matthias Kettwig, Lars Schlotawa et al.
Neuropediatrics
Autoimmune Neurological Disorders and Treatments
article

Early Childhood CASPR2 Autoimmunity with Prominent Autonomic Dysfunction: Diagnostic Challenges and Effective Immunotherapy

Lena Meyer-Ruhnke, Lara Maleen Marten, Matthias Kettwig, Lars Schlotawa, Charlotte Ehl, Jutta Gaertner, Sarah Danica Berger
article en

Abstract

CASPR2-associated neurological diseases cover a broad clinical spectrum, with limbic encephalitis and Morvan syndrome representing the most characteristic autoimmune phenotypes. We report the case of a 2-year-old boy who presented with abdominal and generalized pain, refusal to eat or drink, weight loss, loss of mobility, and behavioral changes, including sleep disturbances. Further clinical evaluation revealed pharmacoresistant arterial hypertension and hyperhidrosis. Extensive diagnostic testing excluded infectious and toxic causes. CASPR2 antibodies were detected in both serum and cerebrospinal fluid. Initial therapy with corticosteroids and intravenous immunoglobulins resulted in only minimal clinical improvement. Significant clinical recovery was only achieved after escalation of immunotherapy with plasmapheresis and subsequent B-cell–depleting therapy with rituximab. At the most recent follow-up visit, seven months after the first rituximab infusion, the patient showed complete recovery without residual symptoms. This case underscores the diagnostic challenges of CASPR2-associated autoimmunity in early childhood and highlights the importance of early recognition of this rare but treatable disease.

Neuropediatrics
Universitätsmedizin Göttingen (DE)
Autoimmune Neurological Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon